A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis. This is the ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the ...

The 9-year-old Harborcreek Township girl used to run around with the other kids on the Rolling Ridge Elementary School ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...

Bronchiolitis is a common lung infection among infants. It can cause coughing, wheezing, and a hard time with breathing. While most cases can be treated at home, it’s also the leading reason ...

Pediatric research explored environmental interventions for bronchiolitis, heart function in children born preterm, and a ...

Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

Bronchiolitis and bronchitis are both infections that affect the lungs and can have overlapping symptoms such as a cough, wheezing, and low-grade fever. However, there are some very important ...

A panelist discusses how axatilimab is particularly effective for patients with bronchiolitis obliterans syndrome, showing ...

Idiopathic obliterative bronchiolitis disorder is rare and has been described in only a few case reports. [7] The illness begins with shortness of breath and a nonproductive cough with no ...